Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells
- 1 December 2014
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 277 (1-2) , 85-95
Abstract
No abstract availableKeywords
Funding Information
- Mashhad University of Medical Sciences (88735)
This publication has 49 references indexed in Scilit:
- Effect of Bavachinin and its derivatives on T cell differentiationInternational Immunopharmacology, 2014
- Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosisGlia, 2012
- Estrogen‐induced protection against experimental autoimmune encephalomyelitis is abrogated in the absence of B cellsEuropean Journal of Immunology, 2011
- Mouse models for multiple sclerosis: Historical facts and future implicationsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Treatment with selective estrogen receptor modulators regulates myelin specific T‐cells and suppresses experimental autoimmune encephalomyelitisGlia, 2008
- Interleukin-10 Therapy—Review of a New ApproachPharmacological Reviews, 2003
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- Low-Dose Estrogen Therapy Ameliorates Experimental Autoimmune Encephalomyelitis in Two Different Inbred Mouse StrainsThe Journal of Immunology, 2001
- The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3Nature Genetics, 2001
- Rate of Pregnancy-Related Relapse in Multiple SclerosisNew England Journal of Medicine, 1998